Trade NKTR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nektar Therapeutics (NKTR) is trading at US$76.41, up 2.99% today as of Sep 8, 12:24 EDT. The company has a market capitalisation of US$2.53B. Over the past 52 weeks, NKTR has traded between US$33.40 and US$109.00. On Syfe you can trade NKTR with $0 commission and add it to your watchlist.
| Previous close | US$74.19 |
|---|---|
| Market cap | US$2.53B |
| 52-week range | US$33.40 – US$109.00 |
| Volume | 607.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nektar Therapeutics
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
Year: 1994
Cantor Fitzgerald Initiates Nektar Therapeutics at Buy With $153 Price Target
Jul 22, 11:18 AM · MT Newswires
Nektar Initiates Two Registrational Trials in Phase 3 Program Evaluating Atopic Dermatitis Treatment
Jul 21, 12:12 PM · MT Newswires
Nektar Therapeutics (NKTR) stock is trading at US$76.41, +2.99% from the previous close of US$74.19.
The market cap for Nektar Therapeutics (NKTR) stock is approximately US$2.53B.
The 52-week high for Nektar Therapeutics (NKTR) stock is US$109.00.
The 52-week low for Nektar Therapeutics (NKTR) stock is US$33.40.
Nektar Therapeutics (NKTR) does not currently pay a dividend.
Stay on top of NKTR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
